Welcome to LookChem.com Sign In|Join Free

CAS

  • or

107759-58-0

Post Buying Request

107759-58-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

107759-58-0 Usage

Uses

N-Succinimidyl-4-(tributylstannyl)benzoate is used as a reactant in the synthesis of urea-based GCPII inhibitors.

Check Digit Verification of cas no

The CAS Registry Mumber 107759-58-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,7,5 and 9 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 107759-58:
(8*1)+(7*0)+(6*7)+(5*7)+(4*5)+(3*9)+(2*5)+(1*8)=150
150 % 10 = 0
So 107759-58-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H8NO4.3C4H9.Sn/c13-9-6-7-10(14)12(9)16-11(15)8-4-2-1-3-5-8;3*1-3-4-2;/h2-5H,6-7H2;3*1,3-4H2,2H3;/rC23H35NO4Sn/c1-4-7-16-29(17-8-5-2,18-9-6-3)20-12-10-19(11-13-20)23(27)28-24-21(25)14-15-22(24)26/h10-13H,4-9,14-18H2,1-3H3

107759-58-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2,5-dioxopyrrolidin-1-yl) 4-tributylstannylbenzoate

1.2 Other means of identification

Product number -
Other names N-succinimidyl p-(tri-n-butylstannyl)benzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:107759-58-0 SDS

107759-58-0Relevant articles and documents

Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer

Alexoff, David,Choi, Seok Rye,Kung, Hank F.,Ploessl, Karl,Yao, Xinyue,Zha, Zhihao,Zhao, Ruiyue,Zhu, Lin

, (2020)

Radioligand therapy (RLT) using prostate-specific membrane antigen (PSMA) targeting ligands is an attractive option for the treatment of Prostate cancer (PCa) and its metastases. We report herein a series of radioiodinated glutamate-urea-lysine-phenylalan

RADIOHALIDE-LABELED TARGETED DIAGNOSTICS AND THERAPEUTICS

-

Paragraph 0158, (2016/03/22)

Disclosed are chemical entities of formula (I) wherein R1, R2 and n are defined herein, and methods of use thereof. These chemical entities are radiative emitters and are useful, e.g., as therapeutic agents for the treatment of, or as diagnostic (e.g., imaging) agents for cancers, e.g., cancers in which PARP1 is overexpressed.

Radiohalogenated for proteins

-

, (2008/06/13)

Haloaryl compounds bearing a defined functional group or precursor are metalated with either Sn(n-Bu)3 or SnMe3. The resulting aryltin compound may be transmetalated in site-specific reaction with one of the following organometallic

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 107759-58-0